Home

intern befreit Gelehrte novo nordisk stellen suchen Im Schande

Novo Nordisk to expand R&D presence in Boston — MedWatch
Novo Nordisk to expand R&D presence in Boston — MedWatch

400 R&D jobs cut as Novo Nordisk says goodbye to inflammatory work
400 R&D jobs cut as Novo Nordisk says goodbye to inflammatory work

Manufacturing
Manufacturing

Danish Insulin Maker Novo Nordisk Cuts Jobs, Shifts R&D Spending - WSJ
Danish Insulin Maker Novo Nordisk Cuts Jobs, Shifts R&D Spending - WSJ

Novo Nordisk will cut 400 jobs and increases its investments in new  innovations - Nordic Life Science – the leading Nordic life science news  service
Novo Nordisk will cut 400 jobs and increases its investments in new innovations - Nordic Life Science – the leading Nordic life science news service

Novo Nordisk announces $750M facility expansion
Novo Nordisk announces $750M facility expansion

Find a job
Find a job

Working at Novo Nordisk | Glassdoor
Working at Novo Nordisk | Glassdoor

Novo Nordisk Official U.S. Career Search Results | Novo Nordisk U.S.
Novo Nordisk Official U.S. Career Search Results | Novo Nordisk U.S.

Novo Nordisk Office Photos | Glassdoor
Novo Nordisk Office Photos | Glassdoor

Novo Nordisk plans price cuts for several insulins
Novo Nordisk plans price cuts for several insulins

Novo Nordisk extends R&D footprint in Boston
Novo Nordisk extends R&D footprint in Boston

Manufacturing
Manufacturing

Novo Nordisk builds R&D capacity in cardiovascular and liver diseases |  Science | AAAS
Novo Nordisk builds R&D capacity in cardiovascular and liver diseases | Science | AAAS

Novo to invest €100M on site in France, adding 250 jobs | Fierce Pharma
Novo to invest €100M on site in France, adding 250 jobs | Fierce Pharma

Danish biopharma Novo Nordisk to add 200-plus jobs in Boston area - Boston  Business Journal
Danish biopharma Novo Nordisk to add 200-plus jobs in Boston area - Boston Business Journal

life- changing careers - Novo Nordisk
life- changing careers - Novo Nordisk

Novo Nordisk
Novo Nordisk

Novo Nordisk expands job cuts to 1,300 as executives play down Lilly's  GLP-1 threat | Fierce Pharma
Novo Nordisk expands job cuts to 1,300 as executives play down Lilly's GLP-1 threat | Fierce Pharma